Evidence map›Paper›PMID 24831610›Full record

ArticlePloS one2014

High-throughput screening of effective siRNAs using luciferase-linked chimeric mRNA.

Shen Pang, Lauren Pokomo, Kevin Chen, Masakazu Kamata, Si-Hua Mao, Hong Zhang, Elliot Razi, Dong Sung An, Irvin S Y Chen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors.Biologicals : journal of the International Association of Biological Standardization · 2018
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shen PangDepartment of Orthopaedic Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Lauren PokomoUCLA School of Nursing, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA and UCLA AIDS Institute, Los Angeles, California, United States of America.
Kevin ChenDepartment of Molecular Genetics and Medicine and AIDS Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Masakazu KamataDepartment of Molecular Genetics and Medicine and AIDS Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Si-Hua MaoDepartment of Molecular Genetics and Medicine and AIDS Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Hong ZhangSchool of Dentistry, University of California Los Angeles, Los Angeles, California, United States of America; Department of Orthodontics, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China.
Elliot RaziDepartment of Orthopaedic Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Dong Sung AnUCLA School of Nursing, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA and UCLA AIDS Institute, Los Angeles, California, United States of America.
Irvin S Y ChenDepartment of Molecular Genetics and Medicine and AIDS Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
University of California, Los Angeles · USBlack AIDS Institute · USSun Yat-sen University · CN

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Genetic protection of hematopoietic stem cells for stable HIV controlR01AI100652 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AN, DONG SUNG · 2012 to 2016
$1.9M
Investigate stability RNA interference human lymphocytesR01HL086409 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AN, DONG SUNG · 2006 to 2009
$1.6M
PRIMATE LENTIVIRUS BASED THERAPY VECTORSR01AI039975 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHEN, IRVIN S.Y. · 1997 to 2005
$1.5M
Intramural NIH HHSNHLBI NIH HHS 3R01HL086409-03S1NHLBI NIH HHS R01 HL086409NIAID NIH HHS AI28697NIAID NIH HHS AI39975NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI039975NIAID NIH HHS R01 AI100652PHS HHS NIH/NIAID AI028697
6 · The paper itself

Abstract

The use of siRNAs to knock down gene expression can potentially be an approach to treat various diseases. To avoid siRNA toxicity the less transcriptionally active H1 pol III promoter, rather than the U6 promoter, was proposed for siRNA expression. To identify highly efficacious siRNA sequences, extensive screening is required, since current computer programs may not render ideal results. Here, we used CCR5 gene silencing as a model to investigate a rapid and efficient screening approach. We constructed a chimeric luciferase-CCR5 gene for high-throughput screening of siRNA libraries. After screening approximately 900 shRNA clones, 12 siRNA sequences were identified. Sequence analysis demonstrated that most (11 of the 12 sequences) of these siRNAs did not match those identified by available siRNA prediction algorithms. Significant inhibition of CCR5 in a T-lymphocyte cell line and primary T cells by these identified siRNAs was confirmed using the siRNA lentiviral vectors to infect these cells. The inhibition of CCR5 expression significantly protected cells from R5 HIV-1JRCSF infection. These results indicated that the high-throughput screening method allows efficient identification of siRNA sequences to inhibit the target genes at low levels of expression.

Indexed as

AlgorithmsCell LineDNAGene Expression ProfilingGene Expression RegulationGene LibraryGenetic VectorsHEK293 CellsHigh-Throughput Screening AssaysHumansLeukocytes, MononuclearLuciferasesPromoter Regions, GeneticReceptors, CCR5RNA InterferenceRNA, Small InterferingCCR5 protein, humanDNALuciferasesReceptors, CCR5RNA, Small Interfering

Identifiers

PMID24831610
PMCPMC4022502
OpenAlexW2093152159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.